Table 2.
Gene name | Gene symbol | Infected vehicle | Anti-Ang2 antibody, % | Anti-TNF antibody, % | Antibody combination, % |
---|---|---|---|---|---|
Anti-Ang2 antibody: suppression of smaller expression increases during infection | |||||
Eph receptor A4 | Epha4 | 1.3 | −115 | −180 | −179 |
Fibulin 2 | Fbln2 | 1.4 | −70 | −117 | −128 |
Fibrillin 1 | Fbn1 | 1.4 | −51 | −66 | −77 |
Serpin B2 | Serpinb2 | 1.5 | −86 | −4 | −97 |
Follistatin | Fst | 1.5 | −72 | −64 | −100 |
Neurotensin | Nts | 2.1 | −77 | −67 | −81 |
Von Willebrand factor | Vwf | 2.2 | −58 | −89 | −111 |
Chemokine (C-C motif) receptor 2 | Ccr2 | 2.3 | −61 | 76 | −27 |
Selectin, endothelial cell | Sele | 4.7 | −50 | −70 | −91 |
Prokineticin 2 | Prok2 | 6.0 | −74 | −95 | −96 |
Anti-TNF antibody and antibody combination: suppression of largest increases with infection | |||||
Selectin, platelet | Selp | 16.6 | −37 | −74 | −83 |
Pro-platelet basic protein | Ppbp | 18.6 | 30 | −80 | −89 |
Colony-stimulating factor 3 receptor | Csf3r | 19.5 | 13 | −45 | −74 |
Schlafen 1 | Slfn1 | 19.7 | 18 | −21 | −57 |
Matrix metallopeptidase 8 | Mmp8 | 20.3 | −30 | −83 | −94 |
Matrix metallopeptidase 3 | Mmp3 | 23.5 | −5 | −58 | −63 |
Chemokine (C-C motif) receptor 1 | Ccr1 | 24.2 | −7 | −24 | −50 |
Chemokine (C-X-C motif) ligand 1 | Cxcl1 | 26.2 | −8 | −46 | −67 |
Formyl peptide receptor 1 | Fpr1 | 27.9 | 0 | −76 | −93 |
Pleckstrin | Plek | 31.9 | 5 | −38 | −67 |
Sclafen 3 | Slfn3 | 49.9 | 10 | −49 | −83 |
Chemokine (C-X-C motif) ligand 10 | Cxcl10 | 56.7 | 0 | −38 | −68 |
IL-1 receptor antagonist | Il1rn | 60.0 | 6 | −42 | −77 |
Chemokine (C-C motif) ligand 3 | Ccl3 | 68.6 | 28 | −52 | −82 |
Formyl peptide receptor 2 | Fpr2 | 79.0 | 12 | −59 | −83 |
Chemokine (C-X-C motif) ligand 3 | Cxcl3 | 83.6 | −18 | −79 | −86 |
C-type lectin domain family 4d | Clec4d | 87.8 | 10 | −50 | −80 |
C-type lectin domain family 4e | Clec4e | 124.3 | 14 | −50 | −85 |
IL-1β | Il1b | 127.9 | 2 | −42 | −75 |
Serum amyloid A3 | Saa3 | 198.8 | 0 | −64 | −62 |
Schlafen 4 | Slfn4 | 203.3 | 5 | −51 | −72 |
Immunoresponsive gene 1 | Irg1 | 229.2 | 7 | −53 | −78 |
Chemokine (C-X-C motif) ligand 2 | Cxcl2 | 280.5 | 4 | −55 | −75 |
S100 calcium binding protein A8 | S100a8 | 282.7 | −10 | −61 | −79 |
S100 calcium binding protein A9 | S100a9 | 324.3 | −8 | −54 | −78 |
Genes with the largest increases during Mycoplasma pulmonis infection (7 days; condition A) ranked by fold increase from pathogen free. Genes included had at least one treatment reduce expression by 50% or more. Treatment with anti-Ang2 antibody alone suppressed genes that underwent more modest increases after infection than with anti-TNF antibody or antibody combination. More negative values indicate greater suppression of the infection-induced increase in expression. A value of −100% indicates complete suppression of the increase, and values <−100% indicate suppression of expression to lower than the pathogen-free level.
Ang2, angiopoietin-2; TNF, tumor necrosis factor.